权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Genetic Suppression of SMN Mutations in Spinal Muscular Atrophy

脊髓性肌萎缩症中 SMN 突变的基因抑制

基本信息

批准号：
10661705
负责人：
ARTHUR H. M. BURGHES
金额：
$ 51.08万
依托单位：
OHIO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-01 至 2026-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10661705
关键词：
Address Affect Alleles Animals Axon Binding Biochemical Biochemical Pathway Biological Assay Birth C-terminal Cell Culture Techniques Cell Line Cell Survival Cells Clustered Regularly Interspaced Short Palindromic Repeats Complement Critical Pathways DNA Sequence Alteration Defect Development Disease Electrophysiology (science)Engineering Excision Exons Genes Genetic Genetic Suppression Human Length Missense Mutation Modeling Motor Motor Neurons Mus Mutate Mutation Neuromuscular Diseases Pathogenesis Pathway interactions Patients Phenotype Proteins RNA RNA Splicing Reporting Role SMN deficiency SMN protein (spinal muscular atrophy)SMN1 gene SMN2 gene Small Nuclear Ribonucleoproteins Spinal Muscular Atrophy Study models System Tertiary Protein Structure Testing Transgenic Mice Translating Translations U7 Small Nuclear Ribonucleoprotein Zebrafish autosome effective therapy loss of function motor neuron function mouse model mutant nervous system disorder overexpression profilin snRNP Biogenesis survival motor neuron gene

项目摘要

Spinal Muscular Atrophy is a devastating neuromuscular disease caused by insufficient amounts of SMN protein. SMA is caused by loss or mutation of the SMN1 gene and retention of the SMN2 gene. The SMN2 gene is a modifier of phenotype where milder SMA cases having more copies of SMN2. Rarely SMA patients have a missense mutation in the SMN1 gene. We can use these mutations and the protein domains they disrupt to study the function of the SMN protein. We have shown that SMA missense mutations are not functional by themselves but can function in the presence of some full-length wild-type SMN protein. Furthermore, we have shown that N and C-terminal SMN missense mutations can complement each other and rescue snRNP assembly in the complete absence of full-length wild-type SMN protein in mice. We have developed cell line that conditionally removes functional SMN to allow us test SMN missense mutations in culture. We have also used this cell line to test for suppressors of the SMNE134K mutation. We have identified a suppressor in the SmF protein that fully restores snRNP assembly lost due to the SMN E134K mutation. We now have a system to screen for suppressors of SMN missense mutations. In this proposal we will test the SmF suppressor we have found in two different SMN E134K mouse models and determine if this mutation rescues the SMA phenotype and survival of the SMA mouse. Thus, we can study the separate functions of SMN in snRNP assembly from the function of SMN in the axon. We will screen for additional suppressors using other SMN patient derived mutations to test other functional domains of SMN. We will investigate the role of SMN in the axon independent of Sm assembly by introducing HuD and truncated forms of SMN into the SMA mice via scAAV9. We have shown in cells that Smn exon2B is not required for cell survival. We will test scAAV9-Smn∆2 in SMA mice to confirm this finding and rescue the SMA phenotype. Finally we will test the role of profilin in axonal function in the SMA mouse using the SMNS230L mutation. Using genetic mutations we can dissect the functions of SMN in splicing and in the axon to resolve the underlying mechanism by which reduced SMN protein causes SMA.

脊髓性肌萎缩症是一种由SMN蛋白量不足引起的破坏性神经肌肉疾病。 SMA是由SMN 1基因缺失或突变以及SMN 2基因保留引起的。SMN 2基因是一种表型修饰者，其中轻度SMA病例具有更多的SMN 2拷贝。SMA患者很少有 SMN 1基因的错义突变。我们可以利用这些突变和它们破坏的蛋白质结构域，研究SMN蛋白的功能。我们已经证明SMA错义突变是没有功能的，它们本身可以发挥作用，但可以在一些全长野生型SMN蛋白存在下发挥作用。此外，我们还显示N和C-末端SMN错义突变可以彼此互补并拯救snRNP组装在小鼠中完全不存在全长野生型SMN蛋白的情况下。我们已经开发出细胞系，有条件地去除功能性SMN以允许我们在培养物中测试SMN错义突变。我们也用该细胞系用于测试SMNE 134 K突变的抑制剂。我们在SmF中发现了一个抑制因子完全恢复由于SMN E134 K突变而丧失的snRNP装配的蛋白质。我们现在有一个系统，筛选SMN错义突变的抑制因子。在本提案中，我们将测试SmF抑制器，我们有在两种不同的SMN E134 K小鼠模型中发现，并确定该突变是否挽救了SMA表型和SMA小鼠的存活率。因此，我们可以研究SMN在snRNP组装中的单独功能， SMN在轴突中的功能。我们将使用其他SMN患者来源的其他抑制剂筛选其他抑制剂突变以测试SMN的其他功能结构域。我们将研究SMN在轴突非依赖性神经元中的作用。通过将HuD和截短形式的SMN经由scAAV 9引入SMA小鼠中，我们有在细胞中显示，Smn外显子2B不是细胞存活所必需的。我们将在SMA小鼠中测试scAAV 9-Smn β 2，证实这一发现并挽救SMA表型。最后，我们将测试profilin在轴突功能中的作用，使用SMNS 230 L突变的SMA小鼠。利用基因突变，我们可以剖析SMN的功能在剪接和轴突中，以解决SMN蛋白减少导致SMA的潜在机制。